Seeking Alpha
25 Mar 2026, 00:44 UTC · 33w ago
Verdict
Headline takes no side. We score BCDA +0.20 across two claims — slightly bullish.
+0.20slightly bullish
More positive than 56% of ticker scores this week
Scored by the NIS engine · methodology.
Search tags
What the story claims
2 claims · scored −1 bearish … +1 bullish
BioCardia reported Q4 2025 revenue of $0.00, in-line with analyst estimates.
So whatZero revenue highlights a lack of commercial viability and ongoing cash burn, which is fundamentally negative for the stock's valuation.
More negative than 93% of claims this week
BioCardia reported Q4 2025 EPS of -$0.06, beating analyst estimates by $0.14.
Continue reading
5 related stories
More positive than 85% of claims this week
Which stocks this story touches
More positive than 56% of ticker scores this week
The company reported an EPS beat for Q4 2025, although it currently generates no revenue.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
39m ago
−31.7%
Price is moving against the score
$0.8260 vs $1.21 close before publication (Mar 24) · not market-adjusted
BCDA chart →
